Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Nexo Therapeutics offers treatments for some of cancer's most intractable targets.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.
Launchpad Therapeutics operates as an antibody-focused precision oncology company.
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Turnstone Biologics is a privately-held clinical stage biotech company.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Dayra Therapeutics manufactures peptide based medicines.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Versant Ventures has invested in 89 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Versant Ventures's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 15 different industry categories.
Among tracked funding rounds, Abdera Therapeutics received $142.0M in a Series B round. Versant Ventures's total known invested capital is $6.1B.
Versant Ventures's average investment size is $68.2M across its portfolio of 89 companies.
Recent Versant Ventures portfolio additions include Nexo Therapeutics, Abdera Therapeutics, Capsida Biotherapeutics, Belharra Therapeutics, Launchpad Therapeutics. These companies were founded in 2020 or later.